These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30262909)

  • 21. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
    Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.
    Gamelin FX; Aucouturier J; Iannotti FA; Piscitelli F; Mazzarella E; Aveta T; Leriche M; Dupont E; Cieniewski-Bernard C; Montel V; Bastide B; Di Marzo V; Heyman E
    J Physiol Biochem; 2016 Jun; 72(2):183-99. PubMed ID: 26880264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels.
    Iannotti FA; Silvestri C; Mazzarella E; Martella A; Calvigioni D; Piscitelli F; Ambrosino P; Petrosino S; Czifra G; Bíró T; Harkany T; Taglialatela M; Di Marzo V
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2472-81. PubMed ID: 24927567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment.
    Butchart LC; Terrill JR; Rossetti G; White R; Filipovska A; Grounds MD
    Int J Biochem Cell Biol; 2018 Jun; 99():52-63. PubMed ID: 29578051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
    Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
    Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes.
    Weller C; Zschüntzsch J; Makosch G; Metselaar JM; Klinker F; Klinge L; Liebetanz D; Schmidt J
    J Neurosci Res; 2012 May; 90(5):1067-77. PubMed ID: 22253213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractal dimension analysis reveals skeletal muscle disorganization in mdx mice.
    Cury SS; Freire PP; Martinucci B; Dos Santos VC; de Oliveira G; Ferretti R; Dal-Pai-Silva M; Pacagnelli FL; Delella FK; Carvalho RF
    Biochem Biophys Res Commun; 2018 Sep; 503(1):109-115. PubMed ID: 29852164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor 1 is a major mediator of renal fibrosis.
    Lecru L; Desterke C; Grassin-Delyle S; Chatziantoniou C; Vandermeersch S; Devocelle A; Vernochet A; Ivanovski N; Ledent C; Ferlicot S; Dalia M; Saïd M; Beaudreuil S; Charpentier B; Vazquez A; Giron-Michel J; Azzarone B; Durrbach A; François H
    Kidney Int; 2015 Jul; 88(1):72-84. PubMed ID: 25760323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice.
    Tomas-Roig J; Piscitelli F; Gil V; Del Río JA; Moore TP; Agbemenyah H; Salinas-Riester G; Pommerenke C; Lorenzen S; Beißbarth T; Hoyer-Fender S; Di Marzo V; Havemann-Reinecke U
    Behav Brain Res; 2016 Apr; 303():34-43. PubMed ID: 26815100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
    Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU
    Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity.
    Argueta DA; DiPatrizio NV
    Physiol Behav; 2017 Mar; 171():32-39. PubMed ID: 28065722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.